Towards Interpretable Drug-Drug Interaction Prediction: A Graph-Based Approach with Molecular and Network-Level Explanations

πŸ“… 2025-07-12
πŸ“ˆ Citations: 0
✨ Influential: 0
πŸ“„ PDF

career value

178K/year
πŸ€– AI Summary
Existing DDI prediction methods suffer from two key limitations: (1) neglecting contextual dependencies between drug pairs, and (2) difficulty in jointly modeling molecular structures and biological networks to yield mechanistic interpretability. To address these, we propose a unified drug-pair modeling framework that treats each drug pair as a holistic entity. Our approach enables multi-scale representation learning via context-aware subgraph pooling and attention-guided influence pooling, and further enhances interpretability and representation diversity through mutual information minimization regularization. Technically, the framework integrates local subgraph extraction, hierarchical interaction graph construction, knowledge graph embedding, and graph neural network (GNN) techniques. Extensive experiments on multiple standard DDI benchmark datasets demonstrate significant improvements over state-of-the-art methods. Ablation studies and embedding visualizations validate the effectiveness of individual components and provide biologically meaningful insights into underlying DDI mechanisms.

Technology Category

Application Category

πŸ“ Abstract
Drug-drug interactions (DDIs) represent a critical challenge in pharmacology, often leading to adverse drug reactions with significant implications for patient safety and healthcare outcomes. While graph-based methods have achieved strong predictive performance, most approaches treat drug pairs independently, overlooking the complex, context-dependent interactions unique to drug pairs. Additionally, these models struggle to integrate biological interaction networks and molecular-level structures to provide meaningful mechanistic insights. In this study, we propose MolecBioNet, a novel graph-based framework that integrates molecular and biomedical knowledge for robust and interpretable DDI prediction. By modeling drug pairs as unified entities, MolecBioNet captures both macro-level biological interactions and micro-level molecular influences, offering a comprehensive perspective on DDIs. The framework extracts local subgraphs from biomedical knowledge graphs and constructs hierarchical interaction graphs from molecular representations, leveraging classical graph neural network methods to learn multi-scale representations of drug pairs. To enhance accuracy and interpretability, MolecBioNet introduces two domain-specific pooling strategies: context-aware subgraph pooling (CASPool), which emphasizes biologically relevant entities, and attention-guided influence pooling (AGIPool), which prioritizes influential molecular substructures. The framework further employs mutual information minimization regularization to enhance information diversity during embedding fusion. Experimental results demonstrate that MolecBioNet outperforms state-of-the-art methods in DDI prediction, while ablation studies and embedding visualizations further validate the advantages of unified drug pair modeling and multi-scale knowledge integration.
Problem

Research questions and friction points this paper is trying to address.

Predict drug-drug interactions with interpretable graph-based methods
Integrate molecular and network-level data for mechanistic insights
Overcome independent drug pair modeling limitations in DDI prediction
Innovation

Methods, ideas, or system contributions that make the work stand out.

Integrates molecular and biomedical knowledge graphs
Uses context-aware and attention-guided pooling strategies
Employs mutual information minimization for embedding diversity
πŸ”Ž Similar Papers
πŸ’Ό Related Jobs
Postdoctoral Fellow – AI-Driven Multi-Omics Integration for Predictive Toxicology
Pfizer
The annual base salary for this position ranges from $64,600.00 to $107,600.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 7.5% of the base salary. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility.
Hybrid